ASHLEY GOULD: Open Payments
NPI 1386130094 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,647 in 259 payments from 21 companies in 2025. Trend: 2023 $1,603 · 2024 $2,942 · 2025 $4,647
Food & beverage: $4,647
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 42 | $1,216 |
| Otsuka America Pharmaceutical, Inc. | 42 | $725 |
| ABBVIE INC. | 42 | $529 |
| Vanda Pharmaceuticals Inc. | 19 | $347 |
| Lundbeck LLC | 24 | $313 |
| Supernus Pharmaceuticals, Inc. | 13 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $197 |
| Neos Therapeutics, LP | 19 | $162 |
| Janssen Pharmaceuticals, Inc | 7 | $139 |
| Alkermes, Inc. | 5 | $98 |
Products named: Auvelity, REXULTI, VRAYLAR, HETLIOZ, Qelbree, CAPLYTA, Adzenys XR-ODT, SPRAVATO.
Industry payments across OH — which companies pay providers there.
